Zebiao Cao

Gut microbiota mediates the pro-pyroptosis effect of xierezhuyubuxu decoction in hepatocellular carcinoma

Gut microbiota mediate the alleviation effect of Xiehuo-Guzheng granules on β cell dedifferentiation in type 2 diabetes mellitus

The improvement of modified Si-Miao granule on hepatic insulin resistance and glycogen synthesis in type 2 diabetes mellitus involves the inhibition of TNF-α/JNK1/IRS-2 pathway: network pharmacology, molecular docking, and experimental validation

Correction: The improvement of modified Si-Miao granule on hepatic insulin resistance and glycogen synthesis in type 2 diabetes mellitus involves the inhibition of TNF-α/JNK1/IRS-2 pathway: network pharmacology, molecular docking, and experimental validation

Shentao Ruangan formula promotes apoptosis via the E2F2-p53 pathway in hepatocellular carcinoma

Highly expressed centromere protein L indicates adverse survival and associates with immune infiltration in hepatocellular carcinoma

Hantangping-a traditional Chinese medicine compound versus metformin for treating early type 2 diabetes mellitus:study protocol for a non-inferiority randomized controlled trial

Identification of potential bioactive compounds and mechanisms of GegenQinlian decoction on improving insulin resistance in adipose, liver, and muscle tissue by integrating system pharmacology and bioinformatics analysis

Increased E2F2 predicts poor prognosis in patients with HCC based on TCGA data

Elevated CDK5R1 predicts worse prognosis in hepatocellular carcinoma based on TCGA data

Increased E2F2 predicts poor prognosis in patients with HCC based on TCGA data

Increased E2F2 predicts poor prognosis in patients with HCC based on TCGA data

Increased E2F2 predicts poor prognosis in patients with HCC based on TCGA data

Increased E2F2 predicts poor prognosis in patients with HCC based on TCGA data